[1]宁永波,王雅兴,陈香颖,等.名中医王瑞平“期证相合”理论在肺癌术后研究肿瘤微环境经验[J].陕西中医,2023,(10):1448-1451.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.026]
　NING Yongbo,WANG Yaxing,CHEN Xiangying,et al.Wang Ruiping's theory of “phase correspondence” in postoperative lung cancer patients[J].,2023,(10):1448-1451.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.026]
点击复制

名中医王瑞平“期证相合”理论在肺癌术后研究肿瘤微环境经验
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年10期
页码:
1448-1451
栏目:
名中医经验
出版日期:
2023-10-05

文章信息/Info

Title:
Wang Ruiping's theory of “phase correspondence” in postoperative lung cancer patients
作者:
宁永波; 王雅兴; 陈香颖; 陈嘉齐; 吴存恩; 王瑞平
(南京中医药大学附属医院肿瘤内科,江苏 南京 210004)
Author(s):
NING Yongbo; WANG Yaxing; CHEN Xiangying; CHEN Jiaqi; WU Cun'en; WANG Ruiping
(Department of Medical Oncology,Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing 210004,China)
关键词:
肺癌;  术后分期;  肿瘤微环境;  癌毒;  辨证论治
Keywords:
Lung cancer;  Postoperative staging;  Tumor microenvironment;  Cancer toxicity;  Syndrome differentiation and treatment
分类号:
R 734.2
DOI:
DOI:10.3969/j.issn.1000-7369.2023.10.026
文献标志码:
A
摘要:
王瑞平教授根据多年的临床经验将肺癌术后病理变化归结为正虚与邪实相争,正虚责于脾肺气虚,邪实则为术后残留之癌毒与用药稽留之药毒,二者常与血瘀、痰热、水湿等病理因素交结攻伐人体,而致正气虚,邪气盛。王教授认为一病多期是肺癌术后的基本病理状态,根据术后临床表现与癌毒动态变化可分为毒留期、毒郁期、毒恋期,并与肺癌术后瘀阻毒炽、痰热毒聚、正虚毒结证相合诊疗。治疗时权衡标本虚实之轻重,遵循“急攻缓补”的治疗原则,酌情施以化瘀、清热、补虚之法并将补脾益肺与抗癌解毒贯穿治疗始终,从而改善“血液高凝”“炎-癌转化”“免疫抑制”相关肿瘤微环境,提高术后患者生活质量,延长术后生存期。
Abstract:
Based on years of clinical experience,Prof.Wang Ruiping attributed the postoperative pathological changes of lung cancer to the competition between positive deficiency and evil reality.The positive deficiency is attributed to the deficiency of spleen and lung qi,while the evil reality is the cancer toxicity left after surgery and the drug toxicity retained by drugs.According to Prof.Wang,multiple stages of lung cancer is the basic pathological state after lung cancer surgery,which can be divided into toxic retention stage,toxic depression stage and toxic love stage according to postoperative clinical manifestations and dynamic changes of cancer toxicity,and combined with postoperative lung cancer stasis and toxic incandescence,phlegm-heat and toxic gathering,and positive deficiency and toxic love.The treatment is based on the principle of “urgent attack and slow remedy”,and the methods of resolving blood stasis,clearing heat,and tonifying deficiency are applied as appropriate,the treatment is based on tonifying the spleen and benefiting the lung and detoxifying the cancer,it can improve the microenvironment of tumor related to “blood hypercoagulation”,“inflammation-cancer transformation” and “immunosuppression”,improve patients' postoperative quality of life and prolong their survival.

参考文献/References:

[1] Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2021,71(3):209-249.
[2] 中华人民共和国国家卫生健康委员会.原发性肺癌诊疗指南(2022年版)[J].中国合理用药探索,2022,19(9):1-28.
[3] 郑佳彬,李冰雪,程倩雯,等.非小细胞肺癌患者术后中医药治疗研究进展[J].中国肿瘤临床与康复,2017,24(1):125-128.
[4] 秦甜甜,袁倩倩,牛廷献,等.中草药有效提取物抑制肝细胞癌机制的研究进展[J].湖北中医药大学学报,2023,25(2):122-126.
[5] Wang Y,Zhang Q,Chen Y,et al.Antitumor effects of immunity-enhancing traditional Chinese medicine[J].Biomedicine & Pharmacotherapy,2020,121:109570.
[6] Wang S,Long S,Deng Z,et al.Positive role of Chinese herbal medicine in cancer immune regulation[J].The American Journal of Chinese Medicine,2020,48(7):1577-1592.
[7] 陶李蕙苹,赖岳阳,李 柳,等.基于癌毒病机理论辨治肺癌探讨[J].中华中医药杂志,2023,38(1):214-217.
[8] 赵延华,周仲瑛,吴勉华,等.基于癌毒理论探讨“抗癌解毒药”[J].中华中医药杂志,2022,37(12):7146-7149.
[9] 何 杰,刘 槟,王 菁,等.从血小板探讨血瘀证与肿瘤化疗耐药的关系及活血法作用机制[J].世界中医药,2023,18(3):440-444.
[10] 肖真真,朱燕娟,刘译鸿,等.非小细胞肺癌中医辨证分型与肿瘤免疫微环境的关系[J].中医肿瘤学杂志,2022,4(4):14-20.
[11] 袁 月,李 琳.非小细胞肺癌根治术后复发转移危险因素研究进展[J].中国医学前沿杂志:电子版,2023,15(1):40-45.
[12] 张传龙,姜晓晨,庞 博,等.基于“热极成毒”理论探讨肺“炎-癌转化”与防治思路[J].北京中医药大学学报,2022,45(3):291-295.
[13] 李孟佳.热类邪气及其相关理论的研究[D].哈尔滨:黑龙江中医药大学,2022.
[14] 朱甜甜,刘培民,李东东.天然化合物通过细胞焦亡途径抗肿瘤作用的研究进展[J].中华中医药学刊,2023,44(7):1-12.
[15] 曾普华.从炎性微环境探析肿瘤恶病质的“癌毒致虚”病机观[J].陕西中医,2021,42(8):987-990.
[16] 郭红磊,王爱迪,刘宝山.基于细胞焦亡理论探讨“炎-癌转化”与中医药防治肿瘤思路[J].中医药信息,2023,40(5):1-6.
[17] 刘宜峰,曹 磊,杨 华,等.薏苡仁汤加减内外合治对急性痛风性关节炎湿热痹阻证炎症因子的影响[J].中国实验方剂学杂志,2020,26(9):75-80.
[18] 卢锡南,陈 佳,俞万钧,等.肿瘤微环境中的基质细胞在肺癌发生发展中的作用机制[J].生命的化学,2022,42(11):2034-2045.
[19] 张小力,刘 芹,刘宝瑞.重楼皂苷抗肿瘤及调节肿瘤免疫微环境研究进展[J].陕西中医,2021,42(11):1640-1643.
[20] 张素芳,吕 祥.中医药对非小细胞肺癌根治术后患者免疫功能的影响[J].世界中医药,2020,15(16):2414-2417.
[21] 田建辉.扶正治癌调控肿瘤免疫研究[J].肿瘤防治研究,2021,48(6):565-569.

相似文献/References:

[1]刘海涛 ,衣秀秀,田建辉△.肺癌中西医抗凝治疗研究进展*[J].陕西中医,2020,(1):127.
[2]邵翠丽,周晋华△,杨勤军,等.周晋华运用环磷酰胺联合中药紫杉治疗晚期肺癌经验*[J].陕西中医,2020,(2):223.
　SHAO Cuili,ZHOU Jinhua,YANG Qinjun,et al.ZHOU Jinhua treats advanced lung cancer with cyclophosphamide and purple shirt[J].,2020,(10):223.
[3]汪 莉,杜红旭,周正国,等.攻癌固真汤联合吉非替尼治疗肺癌气虚血瘀证疗效及对患者血流状态的影响[J].陕西中医,2021,(3):338.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.017]
　WANG Li,DU Hongxu,ZHOU Zhengguo,et al.Clinical effect of Gong'ai Guzhen decoction combined with gefitinib in treating lung cancer with Qixu Xueyu syndrome and affect blood flow state[J].,2021,(10):338.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.017]
[4]郑 茜,刘远婷,丁甜甜,等.消积抑癌方对Lewis肺癌荷瘤小鼠MMP-2的影响[J].陕西中医,2021,(7):844.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.007]
　ZHENG Qian,LIU Yuanting,DING Tiantian,et al.Effect of Xiaoji Yi'ai recipe on MMP-2 in Lewis lung cancer bearing mice[J].,2021,(10):844.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.007]
[5]刘文佳,刘宗凯,初晓苏,等.山慈菇-王不留行干预肺癌向骨转移过程生物信息学作用机制[J].陕西中医,2021,(9):1302.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.041]
[6]杨 昕,李和根.肺癌辨证分型研究进展[J].陕西中医,2021,(9):1313.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
　YANG Xin,LI Hegen.Progress in syndrome differentiation of lung cancer[J].,2021,(10):1313.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
[7]李 健,贾 瑞,王 超,等.健脾益气汤联合化疗对肺癌术后患者免疫功能的影响[J].陕西中医,2023,(4):459.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.011]
　LI Jian,JIA Rui,WANG Chao,et al.Effect of Jianpi Yiqi decoction combined with chemotherapy on immune function in patients with lung cancer after surgery[J].,2023,(10):459.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.011]
[8]张 尤,陈 炜.名中医韩明向基于“一本四证”论治肺癌经验[J].陕西中医,2023,(12):1788.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.027]
[9]陈香颖,宁永波,王雅兴,等.名中医王瑞平运用“培土生金法”治疗肺癌经验[J].陕西中医,2024,(4):536.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.023]
　CHEN Xiangying,NING Yongbo,WANG Yaxing,et al.Experience of professor Wang Ruiping using “tonifying the spleen and replenishing the lung” to treat lung cancer[J].,2024,(10):536.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.023]
[10]王 倩,蒋思雨,刘倩希,等.加味麦门冬汤联合安罗替尼治疗晚期驱动基因阴性非小细胞肺癌临床疗效[J].陕西中医,2024,(8):1048.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.008]
　WANG Qian,JIANG Siyu,LIU Qianxi,et al.Clinical efficacy of modified Maimendong decoction combined with anlotinib on advanced driver gene-negative non-small cell lung cancer[J].,2024,(10):1048.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.008]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(82104950); 江苏省中医院院级课题(Y2020CX67)
更新日期/Last Update: 2023-10-09